Published in

Bentham Science Publishers, Recent Patents on Endocrine, Metabolic and Immune Drug Discovery, 3(6), p. 218-223

DOI: 10.2174/187221412802481702

Links

Tools

Export citation

Search in Google Scholar

Perspectives of New Therapies for Endometriosis

Journal article published in 2012 by Jenny V. Garmendia, Juan B. De Sanctis ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Endometriosis is an inflammatory disease characterized by the presence of endometrial glandular epithelial and stromal cells growing in the extra-uterine environment. The disease affects: ovarian function, oocyte quality, embryo development and implantation, and uterine function resulting in infertility or spontaneous pregnancy loss. Even though the world's prevalence is above 10 %, an effective treatment has not yet been found. New pharmacological approaches have been designed and patented that could serve as future therapies for this disease.